Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EBS | AMGN | VRTX | GILD | BMY |
| Company | Emergent Biosolutions | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 8.19 | 262.21 | 407.20 | 93.17 | 57.66 |
| High | 8.46 | 264.73 | 410.82 | 94.25 | 57.88 |
| Low | 8.12 | 261.76 | 406.02 | 92.98 | 57.51 |
| Last | 8.39 | 263.63 | 410.31 | 94.23 | 57.77 |
| Change | +0.09 | -0.86 | +2.13 | +0.28 | +0.01 |
| % Change | +1.08% | -0.33% | +0.52% | +0.30% | +0.02% |
| Volume | 367,277 | 915,937 | 778,588 | 1,526,560 | 2,386,369 |
| 20-Day Average Volume | 949,491 | 4,193,305 | 1,803,222 | 7,025,837 | 11,131,599 |
| Previous Close | 8.30 | 264.49 | 408.18 | 93.95 | 57.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.84 | 271.17 | 449.09 | 92.43 | 57.81 |
| 20-Day Raw Stochastic | 25.09% | 32.04% | 31.39% | 87.09% | 52.39% |
| 20-Day Relative Strength | 45.58% | 32.63% | 34.26% | 58.16% | 53.70% |
| Weighted Alpha | +24.59 | -15.25 | -7.69 | +26.07 | +20.29 |
| Today's Opinion | 8% Buy | 88% Sell | 72% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 72% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 72% Buy | 72% Sell | 8% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.76% since 12/18/24 | +1.64% since 12/18/24 | -8.65% since 12/18/24 | +3.58% since 12/18/24 | +1.49% since 12/18/24 |
| Low | 7.70 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 90.27 on 12/19/24 | 56.08 on 12/20/24 |
| High | 8.56 on 12/24/24 | 269.61 on 12/20/24 | 410.82 on 12/26/24 | 94.25 on 12/26/24 | 57.88 on 12/26/24 |
| 1-Month | |||||
| %Chg | -16.40% since 11/26/24 | -6.07% since 11/26/24 | -12.47% since 11/26/24 | +2.84% since 11/26/24 | -1.80% since 11/26/24 |
| Low | 7.70 on 12/20/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 10.43 on 11/29/24 | 283.64 on 11/29/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | +15.18% since 09/26/24 | -17.57% since 09/26/24 | -11.73% since 09/26/24 | +13.13% since 09/26/24 | +15.09% since 09/26/24 |
| Low | 7.03 on 09/27/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 82.82 on 10/01/24 | 50.71 on 09/27/24 |
| High | 12.73 on 11/07/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +27.82% since 06/26/24 | -15.92% since 06/26/24 | -13.75% since 06/26/24 | +35.54% since 06/26/24 | +35.73% since 06/26/24 |
| Low | 5.25 on 08/07/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 15.10 on 07/30/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 449,727 | 142,172,096 | 105,118,176 | 117,086,688 | 117,147,504 |
| Shares Outstanding, K | 54,184 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 1,049,300,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -760,500,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 293,800,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | 114,800,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.59 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.37 on 11/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/06/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 21.08 | 49.21 |